Alejandro Rodriguez-Garcia

Tecnologico de Monterrey, School of Medicine & Health Sciences

Alejandro Rodriguez-Garcia, MD, is a Clinical and Research Professor of Ophthalmology at Tecnologico de Monterrey School of Medicine & Health Sciences. He is also a Director of the Immunology and Uveitis Service at the Institute of Ophthalmology and Visual Sciences, Zambrano-Hellion Hospital; an Academic and Senior Clinical Research Coordinator of the Multicentric Ophthalmology Residency Program; and a former President of the Center for Ocular Inflammatory Disorders of the Mexican Society of Ophthalmology. Dr. Rodriguez-Garcia received the Best Clinical Professor of Medicine Award. He was appointed as a Professor of Ophthalmology with Best Academic Evaluation, as well as a Postgraduate Professor with the Highest Scientific Production at Tecnologico de Monterrey School of Medicine and Health Sciences. He completed a Clinical and Research Fellowship in Ocular Immunology and Uveitis at the Massachusetts Eye and Ear Infirmary, Harvard Medical School.

1books edited

2chapters authored

Latest work with IntechOpen by Alejandro Rodriguez-Garcia

Uveitis is the fifth cause of visual loss in the developed world, accounting for up to 20% of legal blindness. Visual loss due to uveitis currently has a significant impact on the productivity and quality of life of many patients worldwide. Therefore, advances in diagnostic techniques and therapeutic strategies are crucial for patients suffering from the disease. Improvements in our understanding of the pathogenic mechanisms, development of more accurate diagnostic tests, and better treatment alternatives come from the continuous efforts of researchers from all over the world who are committed to improving the standard of care of patients suffering from these potentially blinding diseases.This book focuses on the most recent advances in diagnostic techniques for primary and systemic-associated autoimmune and infectious uveitis, as well as new therapeutic strategies that have significantly reduced the rate of ocular complications and improved the visual outcome of patients suffering from these devastating disorders.

Go to the book